Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention-HARP: Simvastatin to prevent lung injury after oesophagectomy
2007-002454-37Phase 2Completed
- Sponsor
- Royal Group of Hospitals
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute lung injury (ALI) and not applicable; "lung injury" is not a specific disease comparing Simvastatin 40 mg with Placebo (2 arms). Primary endpoint: Pulmonary dead space fraction at 6 hours after one-lung ventilation. Started May 2007; status: completed.
02
Drugs
simvastatin
03
Conditions
acute lung injury (ALI)not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on 2007-002454-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002454-37.